The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > NeoPharm, Inc.

NeoPharm, Inc.
Nasdaq: NEOL
Change
symbol:
     
 PROFILE
NeoPharm develops new drugs to treat various forms of cancer. The company utilizes two technology platforms -- liposome drug delivery and tumor targeting -- to develop its drugs. Its two primary product candidates, liposome encapsulated paclitaxel (LEP) and liposome encapsulated doxorubicin (LED) target solid tumors and breast, blood, and prostate cancers, respectively. NeoPharm's leading tumor-targeting product, IL13-PE38, is designed to attack tumors in kidney and brain cancers. NeoPharm has a worldwide development and licensing agreement with Pharmacia for LEP and LED. Chairman John Kapoor owns more than a quarter of the company.

 COMPETITION
Bristol-Myers Squibb Company (BMY)
Cytoclonal Pharmaceutics Inc. (CYPH)
NaPro BioTherapeutics, Inc. (NPRO)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 3.00
1-Yr. Sales Growth: (72.7)%
Employees: 19
Revenue per employee: $157,894.74

 KEY PEOPLE
• James M. Hussey
    CEO
• Lawrence A. Kenyon
    CFO

 CONTACT INFO
150 Field Dr., Ste. 195
Lake Forest, IL 60045
US
Phone: 847-295-8678
Fax: 847-295-8854

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001